Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Type 2 diabetes

Showing   of 1 results

Sanjay Rajagopalan, MD

Sanjay Rajagopalan, MD, Leads Clinical Trial Showing Mechanism of Benefit of Mineralocorticoid Receptor Antagonist for Patients with Type 2 Diabetes and Chronic Kidney Disease

Innovations in Cardiovascular Medicine & Surgery | Fall 2024

Results are loading...